Very noticeable Deterioration in Revenues at the company over the most recent fiscal period

TBIO declared disappointing most recent fiscal period, where Revenue melted down by -41.976 % to $9.47 millions and TBIO posted a shortfall per share to $-0.28, in contrast to $-0.58, in the comparable interval a year prior.

in proportion to the prior reporting period Income per Share fell from $0.21 per share and Revenue Tumbled by -86.966 % from $72.65 millions.


In the fourth quarter of 2022 Telesis Bio Inc reported net shortfall of $-8.132 million, instead of deficit of $-36.288 millions in the comparable reporting period a year ago.

Furthermore, the TBIO noted as well a shortfall of $-48.47 millions and for the financial year 2022, Revenues of $27.44 millions.

Laboratory Analytical Instruments The Laboratory Analytical Instruments company has decreased it's shortfall per share to $-1.65 from $-2.20 in the prior fiscal year, while Revenue doubled by 251.55 % from $7.80 millions a year prior.

Telesis Bio Inc's Net Income Growth

Telesis Bio Inc's Dividend Pay out

Other TBIO's Earnings Reports

EPS faded while Revenues grown rapidly in the second quarter of 2021 earnings season